Minimal time to successful intercourse after sildenafil citrate: Results of a randomized, double-blind, placebo-controlled trial

被引:62
|
作者
Padma-Nathan, H
Stecher, VJ
Sweeney, M
Orazem, J
Tseng, LJ
deRiesthal, H
机构
[1] Male Clin, Beverly Hills, CA 90212 USA
[2] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA USA
[3] Pfizer Inc, New York, NY USA
关键词
D O I
10.1016/S0090-4295(03)00567-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine the minimal time to successful intercourse after taking sildenafil citrate for erectile dysfunction (ED). Methods. Male patients with ED (mean age 60 years; mean ED duration 7.0 years) who were successfully treated with sildenafil (100 mg) for 2 months or longer were randomized to sildenafil (n = 115) or placebo (n = 113) for 4 weeks of double-blind treatment. Using a stopwatch, patients recorded the time needed to obtain an erection hard enough for sexual intercourse after taking the study drug at least 2 hours after eating. Results. Within 14 and 20 minutes of sildenafil dosing, 35% and 51% of sildenafil-treated patients, respectively, versus 22% and 30% of placebo-treated patients, respectively, had an erection that led to successful intercourse (P < 0.05 for both). The median time to erection leading to successful intercourse after sildenafil dosing was 36 minutes compared with 141 minutes for placebo. Conclusions. In this study, slightly more than one half of a population of prior sildenafil responders achieved an erection that led to successful sexual intercourse within 20 minutes of sildenafil administration, suggesting that the onset of action of sildenafil can be less than 30 minutes in men with ED.
引用
收藏
页码:400 / 403
页数:4
相关论文
共 50 条
  • [1] Efficacy and safety of sildenafil citrate in pulmonary arterial hypertension (PAH): Results of a multinational, randomized, double-blind, placebo-controlled trial
    Rubin, L
    Burgess, G
    Parpia, T
    Badesch, D
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 93A - 93A
  • [2] A placebo-controlled, double-blind trial of sildenafil citrate in women with sexual arousal disorder
    Berman, JR
    Berman, LA
    Toler, SM
    Gill, JM
    Haughie, S
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 97 - 97
  • [3] Double-blind, Placebo-controlled Trial of Sildenafil in Phallometric Testing
    Kolla, Nathan J.
    Klassen, Philip E.
    Kuban, Michael E.
    Blak, Thomas
    Blanchard, Ray
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2010, 38 (04): : 502 - 511
  • [4] A randomized double blind placebo-controlled trial of the effects of sildenafil citrate on uterine blood flow.
    Bernstein, Ira M.
    Jones, Cresta
    Schonberg, Adrienne
    Badger, Gary J.
    Osol, George
    [J]. REPRODUCTIVE SCIENCES, 2008, 15 (02) : 212A - 212A
  • [5] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [6] Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: A double-blind, placebo-controlled, randomized, crossover trial
    Parker, John D.
    Bart, Bradley A.
    Webb, David J.
    Koren, Michael J.
    Siegel, Richard L.
    Wang, Hao
    Malhotra, Bimal
    Jen, Frank
    Glue, Paul
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (08) : 1863 - 1868
  • [7] Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: A randomized, double-blind, placebo-controlled trial
    Montorsi, Francesco
    Padma-Nathan, Harin
    Buvat, Jacques
    Schwaibold, Hartwig
    Beneke, Manfred
    Ulbrich, Ernst
    Bandel, Tiemo-Joerg
    Porst, Hartmut
    [J]. JOURNAL OF SEXUAL MEDICINE, 2004, 1 (02): : 168 - 178
  • [8] Venlafaxine in fibromyalgia: Results of a randomized, placebo-controlled, double-blind trial.
    Zijlstra, TR
    Barendregt, PJ
    van De Laar, MAF
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S105 - S105
  • [9] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    [J]. CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [10] Results of a Prospective Randomized Double-blind, Placebo-controlled Trial Evaluating the Use of Prophylactic Sildenafil Citrate During Radiation Therapy in the Treatment of Prostate Cancer
    Zelefsky, M. J.
    Shasha, D.
    Kollmeier, M.
    Baser, R. E.
    Cox, B.
    Stock, R.
    Ennis, R. D.
    Bar-Chama, N.
    Pei, X.
    Mulhall, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S2 - S2